NO20092092L - Arylsulfamidderivater og fremgangsmater for anvendelse derav - Google Patents
Arylsulfamidderivater og fremgangsmater for anvendelse deravInfo
- Publication number
- NO20092092L NO20092092L NO20092092A NO20092092A NO20092092L NO 20092092 L NO20092092 L NO 20092092L NO 20092092 A NO20092092 A NO 20092092A NO 20092092 A NO20092092 A NO 20092092A NO 20092092 L NO20092092 L NO 20092092L
- Authority
- NO
- Norway
- Prior art keywords
- disorders
- derivatives
- arylsulfamide
- processes
- tautomer
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 6
- 208000035475 disorder Diseases 0.000 abstract 5
- 208000032131 Diabetic Neuropathies Diseases 0.000 abstract 1
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 201000001880 Sexual dysfunction Diseases 0.000 abstract 1
- 230000003542 behavioural effect Effects 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000000407 monoamine reuptake Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 231100000872 sexual dysfunction Toxicity 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 230000001457 vasomotor Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86964406P | 2006-12-12 | 2006-12-12 | |
| PCT/US2007/025405 WO2008073459A1 (en) | 2006-12-12 | 2007-12-12 | Aryl sulfamide derivatives and methods of their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20092092L true NO20092092L (no) | 2009-08-19 |
Family
ID=39273293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20092092A NO20092092L (no) | 2006-12-12 | 2009-05-29 | Arylsulfamidderivater og fremgangsmater for anvendelse derav |
Country Status (20)
| Country | Link |
|---|---|
| US (4) | US20080161366A1 (es) |
| EP (1) | EP2061776A1 (es) |
| JP (1) | JP2010512401A (es) |
| KR (1) | KR20090087506A (es) |
| CN (1) | CN101600701A (es) |
| AR (1) | AR064318A1 (es) |
| AU (1) | AU2007333593A1 (es) |
| BR (1) | BRPI0720289A2 (es) |
| CA (1) | CA2671844A1 (es) |
| CL (1) | CL2007003590A1 (es) |
| CR (1) | CR10866A (es) |
| EC (1) | ECSP099411A (es) |
| MX (1) | MX2009006359A (es) |
| NO (1) | NO20092092L (es) |
| PE (1) | PE20081395A1 (es) |
| RU (1) | RU2009121017A (es) |
| SV (1) | SV2009003295A (es) |
| TW (1) | TW200843753A (es) |
| WO (1) | WO2008073459A1 (es) |
| ZA (1) | ZA200904109B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090156826A1 (en) * | 2007-12-12 | 2009-06-18 | Wyeth | Methods for the preparation of hydroxy-substituted aryl sulfamide compounds |
| GB0813694D0 (en) * | 2008-07-25 | 2008-09-03 | Glaxo Group Ltd | Compounds |
| AU2011223898A1 (en) * | 2010-03-04 | 2012-09-13 | Merck Sharp & Dohme Corp. | Positive allosteric modulators of mGluR2 |
| CN102838567B (zh) * | 2011-06-23 | 2014-12-31 | 深圳市湘雅生物医药研究院 | 一种苯磺酰或苯甲酰哌嗪类化合物及其制备方法和用途 |
| US9205085B2 (en) | 2011-11-07 | 2015-12-08 | Emory University | Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction |
| US9867813B2 (en) * | 2015-11-17 | 2018-01-16 | Thomas Daly | Aminopyridine based buffers with wide buffering ranges, antibiotics and myelin disease therapy |
| CN107337616A (zh) * | 2017-07-13 | 2017-11-10 | 上海昕盛医药科技有限公司 | 一种盐酸班布特罗杂质f的合成方法 |
| CN107445845A (zh) * | 2017-08-24 | 2017-12-08 | 重庆沃肯精细化工有限公司 | 一种合成氯法齐明关键中间体n‑(4‑氯苯基)‑1,2‑苯二胺的方法 |
| IL279476B2 (en) | 2018-06-21 | 2024-04-01 | Cellestia Biotech Ag | Process for making amino diaryl ethers and amino diaryl ethers hydrochloride salts |
| US11091447B2 (en) | 2020-01-03 | 2021-08-17 | Berg Llc | UBE2K modulators and methods for their use |
| CN116003261A (zh) * | 2022-12-19 | 2023-04-25 | 江苏康恒化工有限公司 | 新型聚氨酯扩链剂2-氨基-2’-氯二苯胺的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3177221A (en) * | 1963-02-05 | 1965-04-06 | Mcneilab Inc | 2, 1, 3-benzothiadiazoline-2, 2-dioxides |
| SK94393A3 (en) * | 1992-09-11 | 1994-08-10 | Thomae Gmbh Dr K | Cyclic derivatives of urea, process for their production and their pharmaceutical agents with the content of those |
| ZA966885B (en) * | 1995-08-22 | 1998-02-16 | Du Pont Merck Pharma | Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors. |
| GB9825413D0 (en) * | 1998-11-19 | 1999-01-13 | Lilly Co Eli | Pharmaceutical compounds |
| RU2317988C2 (ru) * | 2000-08-14 | 2008-02-27 | Орто-Макнейл Фармасьютикал, Инк. | Замещенные пиразолы, фармацевтическая композиция на их основе, применение фармацевтической композиции и способ ингибирования активности катепсина s |
| AU2002303406B2 (en) | 2001-04-18 | 2006-03-30 | Euro-Celtique S.A. | Nociceptin analogs |
| MXPA04006344A (es) * | 2001-12-28 | 2005-03-31 | Takeda Pharmaceutical | Preventivos/remedios para la perturbacion de miccion. |
| JP2008539220A (ja) * | 2005-04-26 | 2008-11-13 | ファイザー・リミテッド | バソプレシンアンタゴニストとしてのトリアゾール誘導体 |
| KR20080050453A (ko) * | 2005-09-29 | 2008-06-05 | 와이어쓰 | 모노아민 재흡수에 의해 개선되는 질병의 치료에 사용하기위한 벤조티아디아졸릴페닐알킬아민 유도체 |
-
2007
- 2007-12-11 CL CL200703590A patent/CL2007003590A1/es unknown
- 2007-12-12 BR BRPI0720289-0A patent/BRPI0720289A2/pt not_active Application Discontinuation
- 2007-12-12 PE PE2007001769A patent/PE20081395A1/es not_active Application Discontinuation
- 2007-12-12 MX MX2009006359A patent/MX2009006359A/es not_active Application Discontinuation
- 2007-12-12 CN CNA2007800500208A patent/CN101600701A/zh active Pending
- 2007-12-12 WO PCT/US2007/025405 patent/WO2008073459A1/en not_active Ceased
- 2007-12-12 RU RU2009121017/04A patent/RU2009121017A/ru not_active Application Discontinuation
- 2007-12-12 JP JP2009541360A patent/JP2010512401A/ja not_active Withdrawn
- 2007-12-12 TW TW096147565A patent/TW200843753A/zh unknown
- 2007-12-12 AU AU2007333593A patent/AU2007333593A1/en not_active Abandoned
- 2007-12-12 AR ARP070105585A patent/AR064318A1/es unknown
- 2007-12-12 US US11/955,195 patent/US20080161366A1/en not_active Abandoned
- 2007-12-12 CA CA002671844A patent/CA2671844A1/en not_active Abandoned
- 2007-12-12 EP EP07862811A patent/EP2061776A1/en not_active Withdrawn
- 2007-12-12 US US11/955,204 patent/US20080194654A1/en not_active Abandoned
- 2007-12-12 US US11/955,018 patent/US7601722B2/en not_active Expired - Fee Related
- 2007-12-12 KR KR1020097014272A patent/KR20090087506A/ko not_active Withdrawn
-
2009
- 2009-05-29 NO NO20092092A patent/NO20092092L/no not_active Application Discontinuation
- 2009-06-11 ZA ZA200904109A patent/ZA200904109B/xx unknown
- 2009-06-11 SV SV2009003295A patent/SV2009003295A/es unknown
- 2009-06-12 EC EC2009009411A patent/ECSP099411A/es unknown
- 2009-06-12 CR CR10866A patent/CR10866A/es not_active Application Discontinuation
- 2009-08-27 US US12/548,844 patent/US20100029641A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| SV2009003295A (es) | 2009-10-29 |
| RU2009121017A (ru) | 2011-01-20 |
| PE20081395A1 (es) | 2008-09-17 |
| US20100029641A1 (en) | 2010-02-04 |
| BRPI0720289A2 (pt) | 2014-02-04 |
| CN101600701A (zh) | 2009-12-09 |
| ECSP099411A (es) | 2009-07-31 |
| MX2009006359A (es) | 2009-06-26 |
| CA2671844A1 (en) | 2008-06-19 |
| US7601722B2 (en) | 2009-10-13 |
| JP2010512401A (ja) | 2010-04-22 |
| US20080161366A1 (en) | 2008-07-03 |
| TW200843753A (en) | 2008-11-16 |
| AR064318A1 (es) | 2009-03-25 |
| CL2007003590A1 (es) | 2008-02-29 |
| AU2007333593A1 (en) | 2008-06-19 |
| ZA200904109B (en) | 2010-04-28 |
| US20080167303A1 (en) | 2008-07-10 |
| WO2008073459A1 (en) | 2008-06-19 |
| KR20090087506A (ko) | 2009-08-17 |
| EP2061776A1 (en) | 2009-05-27 |
| US20080194654A1 (en) | 2008-08-14 |
| CR10866A (es) | 2009-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20092092L (no) | Arylsulfamidderivater og fremgangsmater for anvendelse derav | |
| WO2008073956A3 (en) | Cyclic sulfonamide derivatives and methods of their use | |
| EA200970337A1 (ru) | Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения | |
| EA200700851A1 (ru) | Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения | |
| PH12012501122A1 (en) | Pteridinones as inhibitors of polo-like kinase | |
| MX2010009752A (es) | Compuestos de oxadiazoantraceno para el tratamiento de diabetes. | |
| NO20084652L (no) | Deazapuriner anvendelige som inhibitorer av januskinaser | |
| JO3007B1 (ar) | مركبات و تركيبات كمثبطات كيناز بروتين | |
| MX2009002274A (es) | Compuestos de enlace fxr heterociclicos. | |
| EA200801738A1 (ru) | Пиперидиноилпирролидиновые агонисты меланокортинового рецептора 4 типа | |
| NO20076059L (no) | 2,4-Diamino-pyrimidiner anvendt som aurorainhibitorer | |
| MX2010002258A (es) | Compuestos terapeuticos de isoxazol. | |
| CR9347A (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos | |
| EA201100750A1 (ru) | Замещенные диоксопиперидинилфталимидные производные | |
| WO2009036996A3 (en) | Small molecule bradykinin b1 receptor antagonists | |
| NO20085257L (no) | Purinonderivater som HM74a-agonister | |
| NO20085099L (no) | Puritonderivativer som HM74A agonister | |
| NO20085051L (no) | Behandling av gastrointestinale forstyrrelser med CGRP-antagonister | |
| ATE554084T1 (de) | N-hydroxyacrylamidverbindungen | |
| MY173696A (en) | Cyclic amide derivatives as inhibitors of 11-beta- hydroxysteroid dehydrogenase and uses thereof | |
| EA200970065A1 (ru) | Производные пиперазинила, предназначенные для лечения заболеваний, опосредованных рецептором gpr38 | |
| ATE520651T1 (de) | Substituierte phenylmethylbicyclocarbonsäureamidverbindungen | |
| NO20083708L (no) | 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer | |
| WO2009062990A3 (en) | Equilibrative nucleoside transporter ent1 inhibitors | |
| EA201170828A1 (ru) | Конденсированные гетероциклические производные оксадиазола, подходящие для лечения рассеянного склероза |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |